| CLYM Shares Outstanding History Table | ||||||||||||||||||
Below is a table of the CLYM shares outstanding history going back to 8/12/2024:
Also see: CLYM Market Cap History CLYM YTD Return |
As of 7/31/2026 Climb Bio has 57.44 million CLYM shares outstanding. Investors often track the CLYM shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CLYM share count trends over time, with 8 historical shares outstanding datapoints presented, dating back to 8/12/2024.

| CLYM Shares Outstanding History Table | ||||||||||||||||||
Below is a table of the CLYM shares outstanding history going back to 8/12/2024:
Also see: CLYM Market Cap History CLYM YTD Return |
| CLYM Shares Outstanding History Chart | |||||||||||||||||||
CLYM Historical Shares Outstanding: -7.57% CAGR
Mouse over chart for data details
| |||||||||||||||||||
| CLYM Stock Price Chart |
| About Climb Bio Inc |
| Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. Co. is focused on developing therapeutics for patients with immune-mediated diseases. Co.'s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial. We show 8 historical shares outstanding datapoints in our coverage of CLYM's shares outstanding history. Understanding the changing numbers of CLYM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CLYM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CLYM by allowing them to research CLYM shares outstanding history as well as any other stock in our coverage universe. |
| CLYM Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| CLYM Share Performance |
| Shares Outstanding Peers |
| Climb Bio (CLYM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CMAX Shares Outstanding History CMD Shares Outstanding History CMPI Shares Outstanding History CMPX Shares Outstanding History CMRA Shares Outstanding History CMRX Shares Outstanding History CNAT Shares Outstanding History CNC Shares Outstanding History CNCE Shares Outstanding History CNMD Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.